Graft loss from recurrent glomerulonephritis is not increased with a rapid steroid discontinuation protocol

Transplantation

Volumn 81, Issue 2, 2006, Pages 214-219

  Ibrahim, Hassan ^a,b   Rogers, Tyson ^a   Casingal, Vincent ^a   Sturdevant, Mark ^a   Tan, Miguel ^a   Humar, Abhinav ^a   Gillingham, Kristen ^a   Matas, Arthur ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b MMC 736 ^*  (United States)

Author keywords

Glomerulonephritis; Graft loss; Recurrence; Steroid free

Indexed keywords

ACICLOVIR; CLOTRIMAZOLE; COTRIMOXAZOLE; CREATININE; CYCLOSPORIN; DAPSONE; GANCICLOVIR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PENTAMIDINE; PREDNISONE; RAPAMYCIN; STEROID; THYMOCYTE ANTIBODY; TSUKUBAENOLIDE; IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG WITHDRAWAL; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RECIPIENT; RECURRENT DISEASE; RENAL GRAFT DYSFUNCTION; SURVIVAL RATE; TREATMENT OUTCOME; ADOLESCENT; BLOOD; CLINICAL PROTOCOL; GRAFT REJECTION; MIDDLE AGED; MORTALITY;

ADOLESCENT; ADULT; AGED; CLINICAL PROTOCOLS; CREATININE; FEMALE; GLOMERULONEPHRITIS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; STEROIDS; SURVIVAL RATE;

EID: 33644861113     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188656.44326.53     Document Type: Article

References (20)

1. Briganti E, Russ G, McNeil J, et al. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002; 34: 103-109.
2. Pozzi C, Bolasco P, Fogazzi G, et al. Corticosteroids in IgA nephropathy: a randomized controlled trial. Lancet 1999; 353: 883-887.
3. Torres A, Domingues-Gil, Carreno A, Hernandez E, et al. Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy. Kid Int 2001; 61: 219-227.
4. Burgess E. Management of focal segmental glomerulosclerosis: evidence based recommendations. Kidney Int 1999; 55 (supp 70): 26-32.
5. Citterio F. Steroid side effects and their impact on transplantation outcome. Transplantation 2001; 72: S75-S80.
6. Veenstra DL, Best IH, Hornberger J, et al. Incidence and long-term cost of steroid-related side effects after renal transplantation. Am J Kidney Dis 1999; 33: 829-839.
7. Schweizer RT, Rovelli M, Palmeri D, et al. Noncompliance in organ transplant recipients. Transplantation 1990; 49: 374-377.
8. Nevins TE, Kruse L, Skeans MA, Thomas W. The natural history of azathioprine compliance after renal transplantation. Kidney Int 2001; 60: 1565-1570.
9. Montagnino G, Tarantino A, Maccario M, et al. Long-term results with cyclosporine monotherapy in renal transplant patients: a multivariate analysis of risk factors. Am J Kidney Dis 2000; 35: 1135-1134.
10. Sinclair NR. Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group. CMAJ 1992; 147: 645-657.
11. Hricik DE, O'Toole MA, Schulak IA, Herson I. Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a metaanalysis. J Am Soc Nephrol 1993; 4: 1300-1305.
12. Kasiske BL, Chakkera HA, Louis TA, Ma JZ. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. Am Soc Nephrol 2000; 11: 1910-1917.
13. Ahsan N, Hricik D, Matas A, et al. Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - a prospective randomized study. Steroid Withdrawal Study Group. Transplantation 1999; 68: 1865-1874.
14. Birkeland SA. Steroid-tree immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation 2001; 71: 1089-1090.
15. Kandaswamy R, Humar A, Khwaja K, et al. A prospective, randomized study of cyclosporine/CellCept vs. tacrolimus/sirolimus with rapid discontinuation of prednisone (abstract). Am J Transplant 2003; 3: 198.
16. Khwaja K, Asolati M, Hermon I, et al. Outcome at 3 years with a prednisone tree maintenance regimen. Am J Transplant 2004; 4: 980-987.
17. Matas AJ, Ramcharan T, Paraskevas S, et al. Rapid discontinuation of steroids in living donor kidney transplantation: a pilot study. Am J Transplant 2001; 1: 278-283.
18. Kandaswamy R, Melancon K, Dunn T, et al. A prospective randomized trial of steroid free maintenance immunosuppression in kidney transplant recipients - An interim analysis. Am J Transplant 2005; 5: 1529.
19. Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000; 11: 55.
20. Alloway R, Rogers C, Chaudhury R, et al. Early steroid withdrawal does not increase risk for recurrent focal segmental glomerulosclerosis [abstract]. Am J Transplant 2004; 4: 595.